La nueva enzima Cas9 reduce los efectos fuera del objetivo de CRISPR sin una pérdida significativa de actividad en el objetivo | Redes de tecnología
![A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells | Nature Medicine A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells | Nature Medicine](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-018-0137-0/MediaObjects/41591_2018_137_Fig1_HTML.png)
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells | Nature Medicine
![A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells | Nature Medicine A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells | Nature Medicine](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41591-018-0137-0/MediaObjects/41591_2018_137_Fig2_HTML.png)
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells | Nature Medicine
Dynamics changes of CRISPR-Cas9 systems induced by high fidelity mutations - Physical Chemistry Chemical Physics (RSC Publishing)
![A dual conditional CRISPR-Cas9 system to activate gene editing and reduce off-target effects in human stem cells: Molecular Therapy - Nucleic Acids A dual conditional CRISPR-Cas9 system to activate gene editing and reduce off-target effects in human stem cells: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/attachment/505827f4-59db-477d-ab59-fa581f4773b3/fx1_lrg.jpg)
A dual conditional CRISPR-Cas9 system to activate gene editing and reduce off-target effects in human stem cells: Molecular Therapy - Nucleic Acids
![Reducing off-target events in CRISPR genome editing applications with a novel, high-fidelity Cas9 nuclease Reducing off-target events in CRISPR genome editing applications with a novel, high-fidelity Cas9 nuclease](https://image.slidesharecdn.com/hificas9webinar081617finalapproved-170816135918/85/reducing-offtarget-events-in-crispr-genome-editing-applications-with-a-novel-highfidelity-cas9-nuclease-23-320.jpg?cb=1668738056)
Reducing off-target events in CRISPR genome editing applications with a novel, high-fidelity Cas9 nuclease
![Cells | Free Full-Text | Recent Advances in Improving Gene-Editing Specificity through CRISPR–Cas9 Nuclease Engineering Cells | Free Full-Text | Recent Advances in Improving Gene-Editing Specificity through CRISPR–Cas9 Nuclease Engineering](https://www.mdpi.com/cells/cells-11-02186/article_deploy/html/images/cells-11-02186-g001.png)
Cells | Free Full-Text | Recent Advances in Improving Gene-Editing Specificity through CRISPR–Cas9 Nuclease Engineering
![Comparison of CRISPR-Cas9/Cas12a Ribonucleoprotein Complexes for Genome Editing Efficiency in the Rice Phytoene Desaturase (OsPDS) Gene | Rice | Full Text Comparison of CRISPR-Cas9/Cas12a Ribonucleoprotein Complexes for Genome Editing Efficiency in the Rice Phytoene Desaturase (OsPDS) Gene | Rice | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12284-019-0365-z/MediaObjects/12284_2019_365_Fig2_HTML.png)
Comparison of CRISPR-Cas9/Cas12a Ribonucleoprotein Complexes for Genome Editing Efficiency in the Rice Phytoene Desaturase (OsPDS) Gene | Rice | Full Text
![Invitrogen™ TrueCut™ HiFi Cas9 Protein (1 µg/µL) 1 μg/μl, 10 μg Invitrogen™ TrueCut™ HiFi Cas9 Protein (1 µg/µL) | Fisher Scientific Invitrogen™ TrueCut™ HiFi Cas9 Protein (1 µg/µL) 1 μg/μl, 10 μg Invitrogen™ TrueCut™ HiFi Cas9 Protein (1 µg/µL) | Fisher Scientific](https://assets.fishersci.com/TFS-Assets/BID/product-images/HiFi-Cas9-A50574_rb73_650x600.jpg-650.jpg)
Invitrogen™ TrueCut™ HiFi Cas9 Protein (1 µg/µL) 1 μg/μl, 10 μg Invitrogen™ TrueCut™ HiFi Cas9 Protein (1 µg/µL) | Fisher Scientific
![Martin Pacesa on Twitter: "Optimised chRDNA designs achieve higher specificity at the majority of tested sites in primary human T cells compared to an engineered HiFi Cas9 mutant. However, the combination of Martin Pacesa on Twitter: "Optimised chRDNA designs achieve higher specificity at the majority of tested sites in primary human T cells compared to an engineered HiFi Cas9 mutant. However, the combination of](https://pbs.twimg.com/media/E-ScmrvWYAMsxAA.jpg:large)
Martin Pacesa on Twitter: "Optimised chRDNA designs achieve higher specificity at the majority of tested sites in primary human T cells compared to an engineered HiFi Cas9 mutant. However, the combination of
![HiFi Cas9 globally reduces off-target activity with both stable Cas9... | Download Scientific Diagram HiFi Cas9 globally reduces off-target activity with both stable Cas9... | Download Scientific Diagram](https://www.researchgate.net/publication/326851121/figure/fig2/AS:697388222136321@1543281717362/HiFi-Cas9-globally-reduces-off-target-activity-with-both-stable-Cas9-expression-and-RNP.png)
HiFi Cas9 globally reduces off-target activity with both stable Cas9... | Download Scientific Diagram
![How IDT's new HiFi Cas9 mutant is helping to overcome challenges in the clinical application of CRISPR technology | SelectScience How IDT's new HiFi Cas9 mutant is helping to overcome challenges in the clinical application of CRISPR technology | SelectScience](https://www.selectscience.net/images/articles/Untitled-2283402378.jpg)